Examining the Promise of HIV Elimination by 'test and Treat' in Hyperendemic Settings

Overview

Journal AIDS

Specialty Infectious Diseases

Date 2010 Feb 16

PMID 20154580

Citations 142

Authors

Peter J Dodd

Geoff P Garnett

Timothy B Hallett

Affiliations

Soon will be listed here.

Abstract

Background: It has been suggested that a new strategy for HIV prevention, 'Universal Test and Treat', whereby everyone is tested for HIV once a year and treated immediately with antiretroviral therapy (ART) if they are infected, could 'eliminate' the epidemic and reduce ART costs in the long term.

Methods: We investigated the impact of test-and-treat interventions under a variety of assumptions about the epidemic using a deterministic mathematical model.

Results: Our model shows that such an intervention can substantially reduce HIV transmission, but that impact depends crucially on the epidemiological context; in some situations, less aggressive interventions achieve the same results, whereas in others, the proposed intervention reduces HIV by much less. It follows that testing every year and treating immediately is not necessarily the most cost-efficient strategy. We also show that a test-and-treat intervention that does not reach full implementation or coverage could, perversely, increase long-term ART costs.

Conclusion: Interventions that prevent new infections through ART scale-up may hold substantial promise. However, as plans move forward, careful consideration should be given to the nature of the epidemic and the potential for perverse outcomes.

Citing Articles

Assessing index CD4 and associated outcomes at 1-year in a tertiary HIV clinic, KwaZulu-Natal.

Moya Z, Pillay S, Magula N S Afr Fam Pract (2004). 2024; 66(1):e1-e7.

PMID: 38299523 PMC: 10839242. DOI: 10.4102/safp.v66i1.5803.

Determinants of Preexposure Prophylaxis Cascade Among Sexual and Gender Minorities in Nigeria.

Ramadhani H, Crowell T, Nowak R, Adebajo S, Kayode B, Ononaku U Sex Transm Dis. 2023; 50(9):559-566.

PMID: 37277897 PMC: 10527664. DOI: 10.1097/OLQ.0000000000001841.

Guidance on the use of complex systems models for economic evaluations of public health interventions.

Breeze P, Squires H, Ennis K, Meier P, Hayes K, Lomax N Health Econ. 2023; 32(7):1603-1625.

PMID: 37081811 PMC: 10947434. DOI: 10.1002/hec.4681.

Experiences of new diagnoses among HIV-positive persons: implications for public health.

Owusu A BMC Public Health. 2022; 22(1):538.

PMID: 35303863 PMC: 8932052. DOI: 10.1186/s12889-022-12809-6.

HIV incidence, viremia, and the national response in Eswatini: Two sequential population-based surveys.

Nkambule R, Philip N, Reid G, Mnisi Z, Nuwagaba-Biribonwoha H, Ao T PLoS One. 2021; 16(12):e0260892.

PMID: 34855890 PMC: 8639055. DOI: 10.1371/journal.pone.0260892.

References

Morris M, Kretzschmar M . Concurrent partnerships and the spread of HIV. AIDS. 1997; 11(5):641-8. DOI: 10.1097/00002030-199705000-00012. View

Walker P, Hallett T, White P, Garnett G . Interpreting declines in HIV prevalence: impact of spatial aggregation and migration on expected declines in prevalence. Sex Transm Infect. 2008; 84 Suppl 2:ii42-8. DOI: 10.1136/sti.2008.029975. View

Ramjee G, Gouws E . Prevalence of HIV among truck drivers visiting sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis. 2002; 29(1):44-9. DOI: 10.1097/00007435-200201000-00008. View

Jurgens R, Cohen J, Tarantola D, Heywood M, Carr R . Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet. 2009; 373(9669):1079. DOI: 10.1016/S0140-6736(09)60644-9. View

Cremin I, Nyamukapa C, Sherr L, Hallett T, Chawira G, Cauchemez S . Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe. AIDS Behav. 2009; 14(3):708-15. PMC: 2865634. DOI: 10.1007/s10461-009-9592-4. View

Assefa Y, Lera M . Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet. 2009; 373(9669):1080. DOI: 10.1016/S0140-6736(09)60647-4. View

Baggaley R, Garnett G, Ferguson N . Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med. 2006; 3(4):e124. PMC: 1395349. DOI: 10.1371/journal.pmed.0030124. View

Garnett G, Anderson R . Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 9(5):500-13. View

Hallett T, Garnett G, Mupamberiyi Z, Gregson S . Measuring effectiveness in community randomized trials of HIV prevention. Int J Epidemiol. 2007; 37(1):77-87. DOI: 10.1093/ije/dym232. View

10.

Corbett E, Makamure B, Cheung Y, Dauya E, Matambo R, Bandason T . HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS. 2007; 21(4):483-9. DOI: 10.1097/QAD.0b013e3280115402. View

11.

Hallett T, Singh K, Smith J, White R, Abu-Raddad L, Garnett G . Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One. 2008; 3(5):e2212. PMC: 2387228. DOI: 10.1371/journal.pone.0002212. View

12.

Attia S, Egger M, Muller M, Zwahlen M, Low N . Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009; 23(11):1397-404. DOI: 10.1097/QAD.0b013e32832b7dca. View

13.

. Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?. PLoS Med. 2009; 6(9):e1000109. PMC: 2731851. DOI: 10.1371/journal.pmed.1000109. View

14.

Hallett T, Dube S, Cremin I, Lopman B, Mahomva A, Ncube G . The role of testing and counselling for HIV prevention and care in the era of scaling-up antiretroviral therapy. Epidemics. 2011; 1(2):77-82. DOI: 10.1016/j.epidem.2009.02.001. View

15.

Jahn A, Floyd S, Crampin A, Mwaungulu F, Mvula H, Munthali F . Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008; 371(9624):1603-11. PMC: 2387197. DOI: 10.1016/S0140-6736(08)60693-5. View

16.

Laurent C, Bourgeois A, Faye M, Mougnutou R, Seydi M, Gueye M . No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a.... J Infect Dis. 2002; 186(4):486-92. DOI: 10.1086/341833. View

17.

Ruark A, Shelton J, Halperin D, J Wawer M, H Gray R . Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet. 2009; 373(9669):1078. DOI: 10.1016/S0140-6736(09)60642-5. View

18.

Lewis J, Garnett G, Mhlanga S, Nyamukapa C, Donnelly C, Gregson S . Beer halls as a focus for HIV prevention activities in rural Zimbabwe. Sex Transm Dis. 2005; 32(6):364-9. DOI: 10.1097/01.olq.0000154506.84492.61. View

19.

Watson-Jones D, Weiss H, Rusizoka M, Changalucha J, Baisley K, Mugeye K . Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med. 2008; 358(15):1560-71. PMC: 2643126. DOI: 10.1056/NEJMoa0800260. View

20.

Wandel S, Egger M, Rangsin R, Nelson K, Costello C, Lewden C . Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sex Transm Infect. 2008; 84 Suppl 1:i31-i36. PMC: 2569418. DOI: 10.1136/sti.2008.029793. View